|
Dr. Rustin is the Director of Medical Oncology at Mount Vernon Hospital which is the largest cancer center in the South of England. He has published widely on management of gynecological cancers and germ cell tumors and the use of tumor markers. He has developed response criteria on CA125 which are now increasingly used in Phase II trials of ovarian cancer. He has recently been the principal investigator of two trials of vascular targeting agents as well as several trials in ovarian cancer. He was awarded an Honorary Professorship by University College London in March 2001. | 